摘要:
springer.com
sci-hub.se 参考文章(8)
Jonathan Cohen, Jean Carlet, INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group Critical Care Medicine. ,vol. 24, pp. 1431- 1440 ,(1996) , 10.1097/00003246-199609000-00002
Konrad Reinhart, Carola Wiegand-Lohnert, Friedrich Grimminger, Martin Kaul, Stuart Withington, David Treacher, Joachim Eckart, Sheila Willatts, Carmen Bouza, Dietmar Krausch, Felix Stockenhuber, Jurgen Eiselstein, Lothar Daum, Joachim Kempeni, Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Critical Care Medicine. ,vol. 24, pp. 733- 742 ,(1996) , 10.1097/00003246-199605000-00003
E. Abraham, p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group. JAMA. ,vol. 277, pp. 1531- 1538 ,(1997) , 10.1001/JAMA.277.19.1531
T J Evans, D Moyes, A Carpenter, R Martin, H Loetscher, W Lesslauer, J Cohen, Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis. Journal of Experimental Medicine. ,vol. 180, pp. 2173- 2179 ,(1994) , 10.1084/JEM.180.6.2173
Edward Abraham, Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome JAMA. ,vol. 273, pp. 934- 941 ,(1995) , 10.1001/JAMA.1995.03520360048038
Edward Abraham, p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock JAMA. ,vol. 277, pp. 1531- 1538 ,(1997) , 10.1001/JAMA.1997.03540430043031
Charles J. Fisher, Jan M. Agosti, Steven M. Opal, Stephen F. Lowry, Robert A. Balk, Jerald C. Sadoff, Edward Abraham, Roland M.H. Schein, Ernest Benjamin, Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein The New England Journal of Medicine. ,vol. 334, pp. 1697- 1702 ,(1996) , 10.1056/NEJM199606273342603